RULES WERE NOT MEANT FOR THIS BMW. There's a reason the 2 Series is so loved. Blisteringly fast, the 335-horsepower rear-wheel drive M240i Coupe sprints from 0 to 60 mph in just 4.4 seconds, or 4.2 seconds with xDrive, and handles with a steering agility and control that are incredibly precise.
Tecentriq was approved by the U.S. Food and Drug Administration (FDA) for some patients with lung cancer. PUBLISHED: OCTOBER 18, 2016. Be the first to discuss this article on CURE's forum.
Published Online: Monday, Nov 02, 2015. Roger M. Perlmutter, MD, PhD. The FDA has granted a breakthrough therapy designation to pembrolizumab (Keytruda) as a potential therapy for patients with microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC), according to a statement from the company developing the PD-1 inhibitor, Merck.